000 01635 a2200457 4500
005 20250517125346.0
264 0 _c20170621
008 201706s 0 0 eng d
022 _a1528-0012
024 7 _a10.1053/j.gastro.2016.11.021
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDellon, Evan S
245 0 0 _aBudesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
_h[electronic resource]
260 _bGastroenterology
_c03 2017
300 _a776-786.e5 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAnti-Inflammatory Agents
_xadministration & dosage
650 0 4 _aBudesonide
_xadministration & dosage
650 0 4 _aCell Count
650 0 4 _aChild
650 0 4 _aDouble-Blind Method
650 0 4 _aEosinophilic Esophagitis
_xdiagnostic imaging
650 0 4 _aEosinophils
650 0 4 _aEsophagoscopy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aSeverity of Illness Index
650 0 4 _aSuspensions
650 0 4 _aYoung Adult
700 1 _aKatzka, David A
700 1 _aCollins, Margaret H
700 1 _aHamdani, Mohamed
700 1 _aGupta, Sandeep K
700 1 _aHirano, Ikuo
773 0 _tGastroenterology
_gvol. 152
_gno. 4
_gp. 776-786.e5
856 4 0 _uhttps://doi.org/10.1053/j.gastro.2016.11.021
_zAvailable from publisher's website
999 _c26642133
_d26642133